| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
357 |
347 |
$24K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
467 |
448 |
$20K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
221 |
203 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
129 |
120 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
153 |
141 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
65 |
57 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$976.93 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18 |
16 |
$872.96 |
| 0012A |
|
51 |
51 |
$871.53 |
| 0011A |
|
50 |
50 |
$609.86 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
53 |
53 |
$289.66 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$102.06 |
| 91301 |
|
103 |
103 |
$0.00 |
| 99072 |
|
316 |
293 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18 |
12 |
$0.00 |